why would anyone criticise management? I am sure they are doing their best in getting our technology to be noticed...
we are all frustrated with PAT-SC1 not having any takers but we all agreed it may something to do with costs of producing those antibodies on larger scale...Management is working to address that problem
Nothing to do but wait for the next lot of news....there is plenty happening in the background...
Ann: Preliminary Final Report - 30 June 2014, page-45
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 3776088 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 2310786 | 5 |
View Market Depth
| Last trade - 16.12pm 18/09/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable